Meningococcal Disease News and Research

RSS

Lives will be saved as early signs of meningitis now identified

Scientists in the UK say they have identified the early signs of meningitis and blood poisoning which should improve detection of the disease and save lives.

11 Jan 2006

Harvard study finds vaccines boost economies of poor countries

Immunization programs in impoverished countries not only save lives, they boost economies, finds a study by researchers with the Harvard School of Public Health (HSPH) published in the current edition of World Economics.

16 Oct 2005

Significant step forward in the search for a vaccine against Group B meningococcal disease

For a long time, doctors and scientists have suspected that Neisseria lactamica, a harmless germ carried mostly by children under the age of five years, is the key to the development of natural immunity to meningococcal meningitis and septicaemia (blood poisoning).

2 Aug 2005

Infectious diseases pose a serious threat to the nation's public health

Infectious diseases pose a serious threat to the nation's public health. Today, experts addressed key developments to the current and future outlook of infectious diseases, highlighting adolescent immunizations, outbreaks and epidemics of infectious diseases, antimicrobial resistance and new developments in HIV medicine, at a press conference sponsored by the National Foundation for Infectious Diseases (NFID).

27 Jul 2005

The MeNZB vaccine will work

The New Zealand Ministry of Health followed an internationally accepted process for licensing the MeNZB vaccine.

9 Jun 2005

Health Protection Agency publishes report on the benefits of vaccination to children's health

The Health Protection Agency today publishes its first national report on the current status of the UK’s universal vaccine programmes, which protect children against a range of childhood diseases including measles, mumps, rubella and meningitis.

23 May 2005

Meningitis epidemics driven by the wind

A meningitis epidemic hits West Africa every year, affecting 25 000 to 200 000 people. It has long been known that the timing of this epidemic and its spatial distribution within the “Meningitis Belt”, situated between 10° and 15° North, are closely linked to climatic conditions. Involved in the AMMA programme, IRD and University of Paris-VII researcher produced the first quantified description of this relationship using statistical methods.

5 Apr 2005

FDA licenses Sanofi pasteur vaccine for protection against meningococcal disease

Sanofi pasteur, the vaccines business of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has licensed Menactra (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for protection against meningococcal disease in adolescents and adults aged 11-55 years.

17 Jan 2005

Pilgrimage to Mecca comes with a few medical risks

The Hajj or Haj is the Pilgrimage to Mecca (or, "Makkah") and is the fifth of the "Five Pillars of Islam". Every able-bodied Muslim who can afford to do so is obliged to make the pilgrimage to Mecca at least once in a lifetime. Later this month about three million Muslims will gather for this major pilgrimage. But two doctors in this week's BMJ warn that the Hajj carries considerable health risks if the pilgrim is unprepared.

13 Jan 2005

ID Biomedical to supply meningitis C vaccine to the Canadian government

The Canadian government has retained an option to purchase additional product from the Company in the third and final year of the contract. The total value of the contract, including the third year option, could total approximately $30 million to ID Biomedical.

14 Sep 2004

Early success of the meningococcal B immunisation programme celebrated

Experts in science and medicine will focus on New Zealand's Meningococcal B Immunisation Programme today and tomorrow at an Immunisation Conference in Rotorua.

10 Sep 2004

Drug company fights to keep toxin in vaccines

The UK announced Saturday they will remove the mercury preservative Thimerosal from their vaccines. The news comes days after an LA Times article reported that Aventis-Pasteur, a pharmaceutical giant, is pushing to keep the toxin in U.S. vaccines.

13 Aug 2004

College freshmen, beware of dorm diseases

High school graduates have more in common with newborn babies than one would think. Although departing the proverbial family nest, incoming college freshmen need vaccinations, too.

2 Aug 2004

Vermont Department of Health reports that a Chittenden County toddler died over the weekend from meningococcal disease

The child, who attended Ed-U-Care Children's Center in Essex Junction, became ill on Saturday night, was taken to the hospital and died early Sunday morning.

13 Jul 2004

The case of a high school student in King County who died this week of meningococcal disease has created public concern

The case of a high school student in King County who was hospitalized and died this week of meningococcal disease – commonly called bacterial meningitis – has created some public concern about risks of exposure to the disease.

10 Jul 2004

Chiron has received a license for its new meningococcal B vaccine for New Zealand

Chiron developed the vaccine, in close collaboration with the New Zealand Ministry of Health and the Norwegian Institute of Public Health, to protect against the specific meningococcal B strain responsible for a 13-year epidemic in the country.

7 Jul 2004

Pneumococcal vaccination now free in Ontario

The pneumococcal vaccination, the first of three new free child vaccines being introduced by the McGuinty government, is now available, Health and Long-Term Care Minister George Smitherman announced today.

2 Jul 2004

Meningococcal disease: peak season warning

West Australians are being urged to watch out for the signs and symptoms of meningococcal disease as the State heads into the peak season for the potentially deadly infection.

28 Jun 2004

Mathematics helps explain meningococcal meningitis outbreaks

Outbreaks of meningococcal meningitis depend on small differences in the pathogenicity of different bacterial strains, a new report indicates.

22 Jun 2004

Antibiotics given to entire household reduces risk of meningitis

Giving antibiotics to everyone living in the same household as a patient who has had meningitis can substantially reduce the risk of further cases, according to a study in this week's BMJ.

5 Jun 2004